In a significant move, an FDA advisory panel has voted to relax restrictions on several controversial peptides, a decision that is set to shake up the supplement and wellness industries. Despite concerns from some scientists about the safety and efficacy of these compounds, the panel has supported broader access to six specific peptides, igniting discussions about the potential for a burgeoning market. RFK Jr. has been vocal in advocating for the reduction of what he perceives as aggressive suppression of these treatments. The rising popularity of peptides, often promoted by wellness influencers, has raised questions about their effectiveness and safety, with some experts urging caution amidst the growing interest. As the discussions continue, the FDA is expected to outline clearer regulations regarding peptide use, setting the stage for a possible influx of these unproven drugs into the market.